Reducing inequalities in care for patients with non-malignant diseases: Insights from a realist evaluation of an integrated palliative care pathway by Dalkin, Sonia et al.
Citation: Dalkin, Sonia, Lhussier, Monique, Philipson, Pete, Jones, Diana and Cunningham, 
William  (2016)  Reducing  inequalities  in  care  for  patients  with  non-malignant  diseases: 
Insights from a realist evaluation of an integrated palliative care pathway. Palliative Medicine. 
ISSN 1477 030X 
Published by: Sage
URL:  http://dx.doi.org/10.1177/0269216315626352 
<http://dx.doi.org/10.1177/0269216315626352>
This  version  was  downloaded  from  Northumbria  Research  Link: 
http://nrl.northumbria.ac.uk/25744/
Northumbria University has developed Northumbria Research Link (NRL) to enable users to 
access the University’s research output. Copyright © and moral rights for items on NRL are 
retained by the individual author(s) and/or other copyright owners.  Single copies of full items 
can be reproduced,  displayed or  performed,  and given to  third parties in  any format  or 
medium for personal research or study, educational, or not-for-profit purposes without prior 
permission or charge, provided the authors, title and full bibliographic details are given, as 
well  as a hyperlink and/or URL to the original metadata page. The content must  not  be 
changed in any way. Full items must not be sold commercially in any format or medium 
without  formal  permission  of  the  copyright  holder.   The  full  policy  is  available  online: 
http://nrl.northumbria.ac.uk/policies.html
This document may differ from the final, published version of the research and has been 
made available online in accordance with publisher policies. To read and/or cite from the 
published version of the research, please visit the publisher’s website (a subscription may be 
required.)
1 
 
Title: Reducing inequalities in care for patients with non-malignant diseases – 
insights from a realist evaluation of an Integrated Palliative Care Pathway 
 
Sonia Michelle Dalkin*, s.dalkin@northumbria.ac.uk, Department of Public Health and Wellbeing, 
Faculty of Health and Life Sciences, Northumbria University, Coach Lane Campus, Newcastle Upon 
Tyne, NE7 7XA.  
Monique Lhussier, Northumbria University  
Pete Philipson, Northumbria University 
Diana Jones, Northumbria University  
William Cunningham, Hadrian Primary Care Alliance 
 
*Corresponding author  
 
Keywords: palliative care, cancer, non-cancer, realist evaluation, malignant, non-malignant  
 
 
 
 
 
  
2 
 
Abstract  
Background: The need for palliative care is growing internationally with an increasing prevalence of 
non-malignant diseases. The integrated care pathway was implemented in primary care by 
multidisciplinary teams from 2009 in a locality in the North East of England. Fourteen GP practices 
provided data for the study. 
Aim: To find if, how and under what circumstances palliative care registrations are made for patients 
with non-malignant diseases in primary care.  
Design: GP practice data were analysed statistically and qualitative data was collected from health 
care professionals and members of relevant organisations.  
Findings: A mixed effects logistic model indicated a significant difference beyond the 0.1% level (p < 
0.001) in registrations between the malignant and non-malignant groups in 2011, with an odds ratio 
of 0.09 (= exp(-2.4266), indicating that patients in the non-malignant group are around 11 times 
(1/0.09) less likely to be registered than patients in the malignant group. However, patients with 
non-malignant diseases were significantly more likely to be registered in 2012 than in 2011 with an 
odds ratio of 1.46, significant beyond the 1% level. Qualitative analyses indicate that healthcare 
professionals find registering patients with non-malignant diseases stressful, yet feel their 
confidence in treating this population is increasing. 
Conclusions: The ICP began to enable the reduction of inequalities in care by identifying, registering 
and managing an increasing number of palliative patients with non-malignant diseases. Consensual 
and inclusive definitions of palliative care were developed in order to legitimise the registration of 
such patients.  
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What is already known about the topic? 
 The need for palliative care remains much larger than the actual available provision 
internationally, and this is being acknowledged by policy makers and influential 
bodies (1-5).  
 Deaths from chronic and non-malignant disease exceed those from cancer and this 
difference is likely to grow as the population ages (6).  
 Identifying patients with non-malignant diseases who have palliative care needs is 
challenging for health care professionals, these patients have relatively uncertain 
prognoses related to survival and uncertain disease trajectories  (7, 8).  
 Population based studies using random samples of deaths and bereaved carer 
reports indicate that there are more symptom issues in the last year of life in those 
suffering from progressive non-malignant diseases than those suffering from 
malignant diseases (9). 
 It is unknown how and in what circumstances patients dying with non-malignant 
diseases can be identified successfully.  
 
What this paper adds? 
 This study highlights that there is a discrepancy between the number of palliative 
patients with malignant and non-malignant diseases identified in primary care; 
patients with malignant disease are often easier to identify, register and manage.  
 It is essential that definitions of palliative care are inclusive of those patients with 
non-malignant diseases in order to identify appropriate palliative care patients and 
provide care equality. 
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 Health care professionals in primary care have low confidence and high stress when 
placing patients with non-malignant diseases on a palliative care register.  
 Education that legitimises non-malignant patients as appropriate for palliative care 
will increase the appropriate identification of such patients. 
Implications for practice and policy 
 The prevalence of non-malignant diseases is increasing internationally (10); calling 
for policy makers to balance past emphasis on malignant disease with policies and 
guidance for practitioners worldwide to support dying patients with non-malignant 
diseases.  
 The combination of increased prominence of long term conditions and older 
populations is calling for care systems to respond appropriately to ensure equity in 
provision.  
 The Department of Health in England produced the End-of-life care strategy (2) in 
response to these challenges, as it assumes that all patients with palliative care 
needs will be treated the same regardless of diagnosis.  This research highlights that 
more emphasis is needed to translate this ideal of universal provision into practice.  
 
Background 
In a semirural locality in the North East of England, fourteen GP practices covering a population of 
78,000 implemented an Integrated Care Pathway (ICP) in order to improve palliative and end-of-life 
care in 2009/10. The ICP is still in place and is coordinated by a multidisciplinary, multi-
organisational steering group with service user involvement.  It is delivered in line with national 
strategies on Advance Care Planning (ACP) and end-of-life care (2, 3) and aims to provide high 
quality care for all conditions regardless of diagnosis. It requires each GP practice to develop an 
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accurate electronic register of patients through team discussion using an agreed palliative care code, 
emphasising the importance of early identification and registration of those with any life limiting 
illness. This  enables registered patients to have access to a range of interventions such as advance 
care planning, anticipatory medication and the Liverpool Care Pathway for the dying patient (LCP) 
(11).  IŶ oƌdeƌ to ƌegisteƌ patieŶts, health caƌe pƌofessioŶals use the ͚suƌpƌise ƋuestioŶ͛  ǁhich aims 
to identify patients approaching the last year of their life (12). The register is a tool for the 
management of primary care patients; it does not involve family and patient notification. Practice 
teams then use a palliative rather than a curative ethos in consultation by determining patieŶts͛ 
future wishes.  
Descriptive GP practice data analysis had indicated that palliative care registrations had increased 
since the implementation of the ICP but more detailed analysis was required.  The study reported 
here explores:   
- Whether patients with non-malignant diseases were as likely to be registered as 
patients with malignant diseases. Explanation was sought for any discrepancy.  
- Whether there were more registrations of patients specifically with non-malignant 
diseases since the ICP had been implemented.  
- The conditions necessary for equitable palliative care registrations. 
 
Methods  
This study used realist evaluation (13), with its focus on ͚ǁhat ǁoƌks, hoǁ, iŶ which conditions and 
foƌ ǁhoŵ͛ (14) (15). Realist evaluation acknowledges that interventions take place within complex 
social systems (16) and is therefore well suited to studying interventions (or programmes) with 
complex and potentially multiple pathways from implementation to impact. The concepts of Context,  
Mechanism  and  Outcome are used to develop programme theories of how the intervention is 
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supposed to work (13). Mechanisms are understood as being a combination of the resources offered 
by an intervention and the reasoning this enhances in a particular context (17). This alters the 
behaviour of participants, which leads to measurable or observable outcomes.  Empirical data is 
used to test the programme theories to identify how the intervention actually works in practice. (17). 
Our initial programme theory for the ICP stated: Palliative care registrations should increase 
regardless of disease type (outcome) due to a focus on identifying patients early using the 
palliative care register (mechanism) in a health care domain that appreciates the palliative care 
needs of patients (context). 
IŶ oƌdeƌ to ͚test͛ this theory, quantitative data analysis explored variations in palliative care 
registrations across GP practices and then qualitative data explored potential explanations for why 
variations in outcomes might have occurred.  
Routinely collected locality Death Audit data was accessed for 2011/12. Patients were added to the 
register as part of routine care, by their GP who also determined disease type. Logistic regression 
models are used throughout the paper. The response of interest is the number of registrations out 
of the total number of patients, which can be considered as a binomial random variable. The 
explanatory variables of interest are the cancer type (malignant versus non-malignant) and time 
(2012 versus 2011). The sample consisted of all palliative care patients who had died in 2011/12 
from fourteen GP practices.  Any differences between practices are accounted for by including the 
practice as a random effect in a mixed effects logistic model. The software used for the analysis was 
R 3.2.0 (18).  
Three focus groups were conducted throughout 2013. Participants were recruited from the locality 
implementing the ICP via email to each GP practice manager. Focus Group 1 (FG1) aimed to highlight 
how the ICP functioned in practice (twelve attendees: three GPs, two community matrons, two ward 
staff nurses, one social care team lead, one junior doctor, one palliative care unit project manager, 
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one palliative care unit deputy manager, one team leader for the OOH nursing service). FG1 led to a 
detailed mapping of the ICP interventions (19). The maps were set against perceptions of a different 
set of practitioners in Focus Group 2 (FG2). FG2 had eight attendees (two GPs, one MacMillan nurse, 
one ward staff nurse, one community matron, one social care team lead, one district nurse, one 
palliative care unit deputy manager) who refined them. The maps were further refined in Focus 
Group 3 (FG3), which had six attendees (four GPs, one care home manager, one social care team 
lead). 
The study was granted full ethical approval from the NHS Research Ethics Committee (NRES) on 
13.12.2011. Permission was sought to use GP practice data from 14 GP practices and the Research 
and Development (R&D) manager at NHS North of Tyne PCT.  Written informed consent was 
obtained from all participants. 
Findings  
Differences in registrations between malignant and non-malignant diseases.  
Initial histograms using percentages of palliative care patients who subsequently died identified a 
substantial difference between the number of patients registered with malignant and non-malignant 
diseases. Figure 1 shows that substantially more patients with malignant diseases are put on to the 
register than patients with non-malignant diseases, in all practices. However, there is significant 
variability between practices; for example, Practice A registered no patients with non-malignant 
disease who subsequently died, whereas Practice D registered around half of those with non-
malignant disease who subsequently died.  
INSERT FIGURE 1 
A mixed effects logistic model indicated a significant difference beyond the 0.1% level (p < 0.001) in 
registrations between the malignant and non-malignant groups in 2011, with an odds ratio of 0.09 (= 
exp(-2.4266)) indicating that patients in the non-malignant group are around 11 times (1/0.09) less 
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likely to be registered than patients in the malignant group. The associated (approximate) 95% 
confidence interval (0.06, 0.13) suggests that , after allowing for uncertainty patients in the non-
malignant group are less likely to be registered than malignant patients with 7- to 17-fold.lower odds. 
We also observe considerable heterogeneity amongst practices with a variance of 0.41. The mixed 
effects model offers a demonstrably improved fit compared to the main effects model when 
compaƌiŶg theiƌ ǀalues of Akaike͛s IŶfoƌŵatioŶ CƌiteƌioŶ ;AICͿ. 
This analysis therefore supports Figure 1, in showing that significantly more patients with malignant 
disease were registered in 2011 than those with non-malignant disease. This is despite more people 
in the general population dying of non-malignant diseases.  
The use of ratios allows for comparisons of malignant and non-malignant palliative care registrations 
irrespective of practice population size. For example, using ratios, a score of 1 would mean that all 
patients with malignant diseases who died in 2011 were on the register. A score of 0.5 would mean 
only half of these patients were registered.  
In support of the outcome of analysis 1, FG3 highlighted that health care professionals found 
registering patients with non-malignant diseases stressful. This is due to their non-predictable 
trajectory, the difficulty in considering non-malignant patients as appropriate for palliative care and 
the lack of health care professionals involvement in treating progressive symptoms, all of which 
made registration a stressful decision (reasoning).  
GP4 (FG3): ͞Theƌe is stƌess ǁith ŶoŶ-cancer registrations. With a cancer diagnosis 
Ǉou haǀe a fiǆed uŶdeƌlǇiŶg illŶess I thiŶk haǀeŶ’t Ǉou? That the faŵilǇ aƌe aǁaƌe 
of and recognise that their relatives are generally going downhill. But with a non-
cancer diagnosis you know they might have had heart failure for years and years 
aŶd Ǉeaƌs aŶd Ǉes theǇ’ƌe gettiŶg a ďit ǁoƌse ďut theǇ’ǀe had this diagŶosis foƌ 
years.͟  
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The uncertainty linked to a decision to register in such a case means that professionals may be less 
confident about such registrations, and therefore use them less systematically.  
GP5 (FG3): ͞But I still fiŶd it diffiĐult iŶ ŵǇ head ďeĐause theƌe’s a ďlip, Ǉou’ƌe just 
not as confident in putting someone on the board (register) ǁheŶ theǇ’ƌe non-
cancer than Ǉou aƌe if theǇ’ƌe ĐaŶĐeƌ. You’ƌe just Ŷot ĐoŶfideŶt aďout ǁheƌe the 
eŶd poiŶt is goiŶg to happeŶ, hoǁ it’s goiŶg to happeŶ, ǁhat it’s goiŶg to ďe like, 
so theƌe is kiŶd of a ĐoŶfideŶĐe thiŶg aďout it.͟ 
In addition to this, the traffic light system (resource) used in the locality is not as useful when caring 
for patients with non-malignant disease trajectories. This is a local tool, where green signals the 
patient with a life limiting illness is well, amber signals a decline and red identifies end-of-life. 
Patients with non-malignant disease often move between traffic light stages non-linearly meaning 
that if a patieŶt is iŶ ͚gƌeeŶ͛ theǇ could ƋuicklǇ deteƌioƌate to ͚ƌed͛ being nearer the end-of-life, but 
their condition could improve with treatment, becoming ͚gƌeeŶ͛ agaiŶ. This is unlikely to happen to 
patients with malignant diagnoses. Thus, the unpredictable trajectory of non-malignant diseases 
(context) makes decisions about when palliative care is appropriate particularly difficult and may 
help to eǆplaiŶ ǁhǇ health caƌe pƌofessioŶals͛ coŶfideŶce iŶ managing this patient group is low.  
Furthermore, health care professionals described difficulties in viewing patients with non-malignant 
diseases as appropriate for palliative care.   
GP1: ͞I thiŶk it’s ǀeƌǇ diffiĐult ;defiŶitioŶs of palliatiǀe ĐaƌeͿ aŶd it’s soŵethiŶg 
ǁe’ǀe eŶdlesslǇ disĐussed iŶ ouƌ pƌaĐtiĐe, aŶd the ŶoŵeŶĐlatuƌe is ǀeƌǇ ĐoŶfusiŶg, 
and I think cancer treatment makes it even more confusing, for example breast 
ĐaŶĐeƌ, is ofteŶ palliatiǀe ďut it doesŶ’t ŵeaŶ that, theǇ ŵaǇ liǀe a loŶg life, it’s like 
a ĐhƌoŶiĐ illŶess isŶ’t it, the defiŶitioŶ of palliatiǀe has to staƌt to ĐhaŶge, it’s ǀeƌǇ 
difficult, you know, what do you call people? I use the palliative care register and 
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then people get confused that I mean the very end- of-life, the Liverpool pathway, 
it is ǀeƌǇ ĐoŶfusiŶg.͟  
 
Community Matron (FG2): ͞AŶd I thiŶk that eƌŵ, ŵaǇďe soŵetiŵes ǁe do teŶd to, 
when you say palliative care, you do think of cancer diagnoses whereas your COPD 
aŶd heaƌt failuƌes aŶd thiŶgs like that, aŶd I thiŶk theǇ’ƌe Ƌuite diffiĐult fƌoŵ ouƌ 
peƌspeĐtiǀe to kŶoǁ ǁheŶ, Ǉou kŶoǁ if theǇ haǀe aŶ eǆaĐeƌďatioŶ theŶ Ǉes theǇ’ƌe 
really struggling but the next week they could be fine so at what point do you think 
ǁell, theǇ ŵight ďe ƌeadǇ foƌ the pathǁaǇ ;ICPͿ?͟  
The quotes highlight that a GP or community matron who has a palliative care definition inclusive of 
non-malignant diseases may be more likely to register such patients with palliative care needs 
(context). At the commencement of the ICP healthcare professionals regarded palliative care as 
restricted to the care delivered at the actual end-of-life (last 3 days) and struggled to incorporate 
those with non-malignant diseases into their definition of palliative care. Important debates then 
began across the locality concerning the definitions of palliative and end-of-life care. This, along with 
other educational interventions, began to change the culture, with proactive palliative care 
implemented, allowing interventions to be implemented in advance of the actual end-of-life. 
Definitions of and differences between palliative and end-of-life care constitute a debate that is 
outside the remit of this article, but that needs to be acknowledged as having an effect on practice.  
In light of these findings, the programme theory was refined to: The unpredictable trajectory of 
non-cancer illnesses and difficulties in considering non-cancer patients as appropriate for 
palliative care (context), mean that the traffic light system (resource) is less useful when treating 
those with non-malignant diseases.  This results in health care professionals having less 
confidence in registering patients with non-malignant disease (reasoning) and therefore 
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significantly less patients with non-malignant disease were registered in 2011 (outcome), as 
illustrated in Figure 2.  
INSERT FIGURE 2  
 
Increasing registrations of patients with non-malignant diseases  
Data from the 2011 and 2012 Death Audit allowed the number of people who died of malignant and 
non-malignant diseases that were on the register to be identified. To identify if registrations of non-
malignant patients were increasing over time, 2011 data was compared to 2012 data. Table 1 
provides an overview of all deaths in the locality, broken down by registration and disease type. This 
table indicates that the registration of those with non-malignant diseases was increasing from 2011 
to 2012.  
INSERT TABLE 1 
Ratios were calculated for 2011 and 2012 and for each GP practice, using 1) their malignant deaths 
on the register divided by the total malignant deaths that year and 2) the non-malignant deaths on 
the register divided by all non-malignant deaths that year. The mean and standard deviations for 
these ratios are presented in Table 2. The malignant ratios for 2011 and 2012 were then compared, 
and the non-malignant ratios were then compared with each other. Ratios were created in order to 
account for differences in practice population sizes.  
For the malignant group the odds ratio for registrations in 2012 compared to 2011 is 1.78 and is 
significant at the 5% level. The approximate 95% confidence interval for this odds ratio is (1.09, 2.88), 
suggesting that the odds of registration are between 9% and 188% higher in the malignant group. 
The random effects variance of 0.40 indicates that the levels of registrations in the fourteen 
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practices are quite different. Values of AIC from the mixed effects model demonstrated its 
superiority over its fixed effects equivalent. 
From 2011 to 2012, GP practices therefore significantly increased the registrations of patients with 
malignant diseases (outcome).  
INSERT TABLE 2 
In the non-malignant group, patients were significantly more likely to be registered in 2012 than in 
2011 with an odds ratio of 1.46, significant beyond the 1% level. The odds of registration in this 
group have increased from between 10% to 93% after allowing for the uncertainty from the 
approximate 95% confidence interval. Considerable variation between practices was observed via 
the random effects variance of 0.57. Due to this larger value than in other analyses, the difference 
between the fixed effects model and the mixed effects model was larger here with preference once 
more (based on AIC) given to the mixed effects model. 
From 2011 to 2012, GP practices significantly therefore increased the registrations of patients with 
non-malignant diseases (outcome).  
These two statistical tests indicate very important outcomes; between 2011 and 2012 practices 
significantly increased the number of patients registered with both malignant and non-malignant 
disease.  
Due to (1) the already very high rate of registrations in patients with malignant disease recorded in 
2011 and 2012, and (2) health care professionals confidence in providing palliative care for this 
group, investigation into increases in the registrations of patients with non-malignant diseases was 
focused upon.  FGs highlighted that health care professionals now had more understanding about 
non-malignant diagnoses and the relevance and need for appropriate palliative care. This was 
following the publication of the End of Life Care Strategy (2), formal educational events, educational 
13 
 
outreach visits to practice teams (including discussion of nomenclature), feedback of key 
comparative data to teams and informal learning from the ICPs founder.  
GP3 (FG3): ͞I thiŶk its eduĐatioŶ, ƌeallǇ. We’ǀe ďeeŶ eduĐated that ǁe ĐaŶ Ŷoǁ 
think that non-cancer patients require palliative care. And the permission, it’s the 
permission that you can consider non-ĐaŶĐeƌ patieŶts as palliatiǀe.͟ 
 
Health care professionals felt that these forms of education (resource) had legitimised their decision 
to put patients with palliative care needs on the register regardless of diagnosis, which increased 
their confidence to provide palliative care interventions to all appropriate patients (reasoning).  
The increasing numbers of people who will die from non-malignant disease means that the 
identification and registration of those with palliative care needs has to be of same standard as 
those with malignant disease. The participants in FG3 commented upon the changes in cause of 
death in the UK, including increased deaths of patients from non-malignant disease (context).  
GP4 (FG3): ͞I thiŶk the otheƌ thiŶg as ǁell is that people, Ŷot just cancer patients 
but patients with other terminal illnesses such as heart failure due to modern 
medicine are living longer than they ever did and this has kind of filtered down, as 
in days gone by hospices would only take cancer patients whereas now hospices 
will take people with end stage heart failure or end stage COPD and things and 
that’s ďeĐause theǇ’ǀe liǀed loŶgeƌ thaŶ theǇ ǁould haǀe doŶe histoƌiĐallǇ.͟ 
 
However, focus groups highlighted that some health care professionals still have uncertainties about 
the applicability of palliative care to all illnesses, particularly acute exacerbations of a chronic illness 
such as heart failure and Chronic Obstructive Pulmonary Disease (COPD). Yet, in FGs most health 
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care professionals stated that palliative care for those with non-malignant diagnoses was important. 
This suggests that they are aware of the difficulties associated with non-malignant diagnoses and the 
need for and importance of palliative care for these patients. A GP referred to the increasing 
recognition of patients with non-malignant disease being appropriate for palliative care (reasoning).  
GP4 (FG3): ͞That’s ǁhǇ ŵoƌe ŶoŶ-cancer patients are being registered. And 
ďeĐause histoƌiĐallǇ ǁe ǁouldŶ’t haǀe thought of it, palliatiǀe ŵeaŶt ĐaŶĐeƌ 
patieŶts. I thiŶk that’s the ďiggest faĐtoƌ.͟  
 
Figure 3 depicts this; in the context of changes in cause of death and legitimisation that 
palliative care is appropriate for all with terminal illnesses (context) both formal and 
informal education (resource) increased self-efficacy in health care professionals 
registering and providing high quality palliative care  to patients with non-malignant 
disease. This resulted in a significant increase in non-malignant registrations from 2011 
to 2012.  
INSERT FIGURE 3 
 
Conclusions  
Data has shown that there are difficulties in providing palliative care for all patients who need it, due 
to the difficulties of prognostication with non-malignant illnesses. This causes uncertainty and stress 
for health care professionals when deciding to register patients, resulting in less people with non-
malignant diseases being registered. However, overall, health care professionals in the locality are 
increasing their use of palliative care registration. Due to the already high rate of registrations in 
patients with malignant disease, reasons for increases in those with non-malignant disease were 
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pursued. The findings from FGs highlighted that staff are building confidence in registering patients 
with non-malignant disease and this has been legitimised through local policy and practice.   
This study uses mixed methods in order to uncover not only whether palliative care registrations are 
increasing, but also for whom, by what means and in which circumstances. It offers rich data of use 
to researchers, health care professionals and policy makers. However, the findings are based in one 
primary care locality and therefore cannot be generalised without caution. They indicate that 
identifying patients with palliative care needs due to non-malignant disease is difficult and attributes 
this to the unpredictable illness trajectory (7, 8) but does not highlight other barriers to the 
identification of these patients nor effective mechanisms for change.  
The Office of National Statistics reports that in 2013, cancer was the most common broad cause of 
death (29% of all deaths registered) (20). However, diseases of the circulatory system and 
respiratory system accounted for 43% and  ischaemic heart disease, stroke, lower respiratory 
infections and chronic obstructive lung disease have remained the top major killers during the past 
decade (5, 10). The prevalence of dementia is also expected to increase, from 800,000 in 2012 to 
1,000,000 in 2021 in the UK (21). This evidence, alongside the knowledge that the population is 
ageing (22) and cancer treatment is advancing (23), suggests that cancer deaths will continue to 
decrease and non-malignant deaths will increase in the future. It is therefore increasingly important 
for those in clinical practice to reduce inequality by identifying, registering and managing patients 
with palliative care needs who have non-malignant disease to the same standard as those with 
malignant disease. In order to do so, the transition between curative and palliative care needs to be 
better understood for those with non-malignant disease. 
Future research could address whether the recognition of palliative care patients with non-
malignant diseases is growing nationally. Further exploration of the mechanisms by which this is 
occurring, potentially investigating more meso, organisational level mechanisms would be a 
promising research avenue. The need for good quality palliative care services for those with all 
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diagnoses is growing internationally and requires increased skills, expanded capacity, integrated 
services, involvement of the wider community and collaborative working.  
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